178
Participants
Start Date
April 6, 2015
Primary Completion Date
March 31, 2019
Study Completion Date
March 31, 2019
SHAPE measurement (Sonazoid ultrasoud contrast agent)
Three vials with 48 µl of Sonazoid (GE Healthcare, Oslo, Norway) microbubbles (6 ml) will be prepared and drawn into a 10 ml syringe, placed in a syringe pump. Sonazoid will be co-infused at a rate of 0.024 µl/kg body weight/minute (suspension infusion rate of 0.18 ml/kg/hour) together with a 0.9% NaCl solution infused at a rate of at least 2 ml/min.
University of Pennsylvania, Philadelphia
Thomas Jefferson University, Dept of Radiology, Philadelphia
University of Pennsylvania
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Thomas Jefferson University
OTHER